Oral Vancomycin for Preventing Clostridium Difficile Recurrence

NCT03200093 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

65

Enrollment

OTHER

Sponsor class

Stopped Low recruitment due to few eligible participants.

Conditions

Clostridium Difficile Infection

Interventions

DRUG: Oral Vancomycin
DRUG: Placebo

Sponsor

Rochester General Hospital